Piacezno, Poland

Matthias Bochtler

This inventor holds 1 USPTO granted patent. Top assignee: Vilnius University. Active years: 2022.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthias Bochtler: Innovating RNA Research

Introduction

Matthias Bochtler, based in Piacezno, Poland, is a distinguished inventor known for his significant contributions to the field of molecular biology. With one patented invention to his name, his work focuses on advancing gene editing techniques, particularly utilizing CRISPR technology.

Latest Patents

Matthias holds a patent titled "Targeted RNA knockdown and knockout by type III-A Csm complexes." This innovative patent details methods and compositions using CRISPR-Cas Type IIIA, resulting in RNA gene knockdown and knockout in animal models. The implications of this research are vast, potentially enhancing genetic research and therapeutic practices.

Career Highlights

Currently, Matthias is associated with Vilnius University, where he continues to explore and innovate within the realms of gene editing and molecular biology. His work not only contributes to academic understanding but also paves the way for future applications in medicine and genetic engineering.

Collaborations

Throughout his career, Matthias has collaborated with fellow researchers, including Thomas Fricke and Gintautas Tamulaitis. These partnerships have fostered a rich environment for innovation and inquiry, leading to advancements that impact the scientific community.

Conclusion

Matthias Bochtler exemplifies the spirit of innovation through his research and patented inventions. His contributions to the field of RNA research reflect a dedication to pushing the boundaries of science and improving genetic technologies, shaping the future of biological research and therapies.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…